- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02072252
Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men (TODAY!)
Mobile Phone and Internet-Based Intervention for Vulnerable Youth
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to conduct a small randomized controlled trial (RCT) for a 10-week, culturally tailored mobile phone intervention that uses principles of cognitive behavioral therapy (CBT) to reduce anxiety and depression among young men who are sexually attracted to other males.
The primary purpose of the RCT is to collect feedback about the intervention from the participants. This feedback, along with usage data on which features are used more or less often by the participants, and how the features are used, will be evaluated to make improvements to the intervention. The investigators will also assess clinical outcomes (such as anxiety and depressive symptoms). Outcomes will be monitored pre-, mid-, and post-treatment, as well as twice over a 10 week follow-up period.
Study Type
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University Feinberg School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male birth sex and male gender identity
- Reports sexual attraction toward males
- Is between 17-20 years of age
- Is able to speak and read English
- Resides in the Chicago metropolitan area (i.e., Chicago or suburbs of Cook County)
- Currently owns a mobile phone that is compatible with the intervention application, and believes he will be able to keep using this mobile phone for the next 10 weeks
- A score of 10 or more on the Patient Health Questionnaire-9 or 5 or more on the GAD-7
Exclusion Criteria:
- Has visual, hearing, voice, or motor impairment that would prevent completion of study procedures or use of the Internet or mobile phone
- Per self-reported history or the Mini-International Neuropsychiatric Interview, has ever been diagnosed with a psychotic disorder or bipolar disorder, or is currently diagnosed with obsessive compulsive disorder or substance dependence, or has been diagnosed in the past five years with posttraumatic stress disorder, dissociative disorder, or eating disorder; or evidences another condition that indicates this intervention may be insufficient
- Has ever been hospitalized for psychiatric reasons or attempted suicide, or has a score of 4 or more on the Columbia Suicide Severity Rating Scale, or reports non-suicidal self-injury of a nature that suggests this intervention may be insufficient
- Is participating in "Crew 450," "Keep It Up," "My Peeps," or "Q2"
- Reports currently being in Illinois Department of Child and Family Services (DCFS) custody
- Reports currently being in psychotherapy
- Initiation, discontinuation, or adjustment of antidepressant medication in the past 4 weeks
- Less than an 8th grade reading level
- Does not log into the app within 3 days of being sent the link.
- Does not have an email address
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: App teaching cognitive behavioral skills
App teaching cognitive behavioral skills.
This mobile phone application ("app") teaches cognitive behavioral techniques to help participants manage their mood, for example by providing information, interactive tools and tips, and a mood tracker.
A coach will support participants as they use the app via phone calls and email contacts.
|
Mobile phone app teaching cognitive behavioral skills
Other Names:
|
|
No Intervention: Wait-list with referrals
10-week wait-list control condition in which participants will be provided with and encouraged to use mental health referrals to resources in the community.
After the 10-week waiting period, control group participants will have the option to receive the mobile phone application and coaching.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: post-intervention (10 weeks)
|
Self-report measure of depressive symptoms
|
post-intervention (10 weeks)
|
|
GAD-7
Time Frame: post-intervention (10 weeks)
|
Self-report measure of anxiety symptoms
|
post-intervention (10 weeks)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michelle N Burns, Ph.D., Northwestern University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00061284
- K08MH094441 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Symptoms
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
University of California, San DiegoRecruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Treatment Resistant DepressionUnited States
-
Julia EderNot yet recruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Depressive EpisodeGermany
-
Finnish Institute for Health and WelfareUniversity of Helsinki; Tampere University; University of Eastern Finland; Strategic...RecruitingMajor Depressive Disorder | Depressive Symptoms Mild to Moderate in SeverityFinland
-
Uppsala UniversityRecruitingPostpartum | Attachment | Depression - Major Depressive DisorderSweden
-
Mental Health Services in the Capital Region, DenmarkHospital del Mar Research Institute (IMIM); Research Centre of the German Foundation... and other collaboratorsEnrolling by invitationDepression - Major Depressive Disorder | Mental DistressSpain, Germany, Denmark
-
Medical Research CouncilKU LeuvenCompletedDepressive Symptoms | Major Depressive DisorderAustralia
-
Massachusetts General HospitalCompletedMajor Depressive DisorderUnited States, China
-
Dr. Nazanin AlaviCompletedDepression | Depressive Symptoms | Major Depressive DisorderCanada
-
Linkoeping UniversityCompletedMajor Depressive DisorderSweden
Clinical Trials on Mobile Phone Application
-
University Hospitals Cleveland Medical CenterCompleted
-
MelanomaPRO, RussiaPrivolzhsky Research Medical UniversityRecruitingNevus | Nevus, Pigmented | Melanoma (Skin) | Basal Cell Carcinoma | Squamous Cell Carcinoma | Bowen's Disease | Nevus, Spitz | Melanoma in Situ | Nevus Halo | Spot PigmentedRussian Federation
-
Collabree AGUniversity Hospital, Basel, SwitzerlandCompletedHypertension | Medication AdherenceSwitzerland
-
Anjali Raja BeharelleMediService AGCompletedHypertension | Medication AdherenceSwitzerland
-
Mbarara University of Science and TechnologyCompletedmHealth | Maternal Health | MultimediaUganda
-
University of MichiganBlue Cross Blue Shield of Michigan FoundationCompletedDiabetes Mellitus | Prediabetic StateUnited States
-
Baylor College of MedicineU.S. National Science FoundationRecruitingDiabetes Prevention | Obesity and Diabetes Mellitus, Type 2United States
-
General Health Council, MexicoEli Lilly and Company; Instituto de Seguridad y Servicios Sociales de los Trabajadores...RecruitingDiabetes Mellitus, Type 2Mexico
-
Chulalongkorn UniversityThai Red Cross AIDS Research Centre; International AIDS SocietyCompletedHIV Prevention | Adherence, Medication | Adolescent Behavior | Mobile Health | Sexual HealthThailand
-
Amit ArjyalBagmati Rural Municipality, Lalitpur, Nepal; Konjyosom Rural Municipality,... and other collaboratorsNot yet recruitingMaternal Health | Infant Health | Severe Maternal Morbidity | Institutional Delivery | Birth Preparedness and Complication Readiness | Neonatal Adverse OutcomeNepal